OTCMKTS:SMMNY - Siemens Healthineers Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 13
  • Breakdown:
  • 2 Sell Ratings
  • 4 Hold Ratings
  • 7 Buy Ratings
  • 0 Strong Buy Ratings
$28.04
▲ +1.41 (5.30%)
1 month | 3 months | 12 months
Get New Siemens Healthineers Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SMMNY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SMMNY

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 13 analysts offering 12 month price targets for Siemens Healthineers in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $28.04.
Hold
The current consensus among 13 contributing investment analysts is to hold stock in Siemens Healthineers. This rating has held steady since June 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/5/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
11/3/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
2/1/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
5/1/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 1 sell ratings
7/30/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 1 sell ratings
10/28/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 4 hold ratings
  • 2 sell ratings
12/27/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 4 hold ratings
  • 2 sell ratings
1/26/2021

Latest Recommendations

  • 0 strong buy ratings
  • 7 buy ratings
  • 4 hold ratings
  • 2 sell ratings

DateBrokerageActionRatingPrice TargetDetails
1/20/2021Berenberg BankReiterated RatingBuy
i
1/12/2021BarclaysReiterated RatingEqual Weight
i
1/6/2021Stifel NicolausUpgradeHold ➝ Buy
i
12/9/2020Morgan StanleyUpgradeUnderweight ➝ Overweight
i
12/9/2020AlphaValueUpgradeReduce
i
12/3/2020Commerzbank AG (CBK.F)UpgradeHold ➝ Buy
i
12/3/2020Bank of AmericaUpgradeNeutral ➝ Buy
i
11/10/2020Credit Suisse GroupReiterated RatingOutperform
i
10/26/2020Royal Bank of CanadaReiterated RatingSector Perform
i
10/6/2020Deutsche Bank AktiengesellschaftReiterated RatingHold
i
8/18/2020UBS GroupReiterated RatingNeutral
i
8/12/2020BarclaysReiterated RatingEqual Weight
i
7/24/2020UBS GroupInitiated CoverageNeutral
i
7/22/2020Royal Bank of CanadaReiterated RatingSector Perform
i
7/2/2020JPMorgan Chase & Co.Reiterated RatingUnderweight
i
6/8/2020CitigroupUpgradeNeutral ➝ Buy
i
5/26/2020Berenberg BankReiterated RatingBuy
i
5/7/2020Morgan StanleyReiterated RatingUnderweight
i
5/6/2020Credit Suisse GroupReiterated RatingOutperform
i
5/6/2020JPMorgan Chase & Co.Reiterated RatingUnderweight
i
3/31/2020JPMorgan Chase & Co.Reiterated RatingUnderweight
i
9/19/2019JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight
i
(Data available from 1/27/2016 forward)
Siemens Healthineers logo
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and distributes imaging, diagnostic, and advanced therapies products and services to healthcare providers worldwide. The company operates through three segments; Imaging, Diagnostics, and Advanced Therapies. The Imaging segment offers magnetic resonance, computed tomography, X-ray, molecular imaging, and ultrasound systems. The Diagnostics segment provides in-vitro diagnostic products and services to healthcare providers in laboratory, molecular, and point-of-care diagnostics; and workflow solutions and informatics products. The Advanced Therapies segment offers integrated products, solutions, and services for therapy departments of healthcare providers; and robotic-assisted platform for endo-vascular coronary and peripheral vascular interventions. This segment's principal products include angiography systems and mobile C-arms. It also provides customer value chain services, including design, maintenance, operational management, training, and education services. In addition, the company offers equipment performance management, clinical education and e-learning, asset management, and managed departmental services, as well as digital health products and services. The company is headquartered in Erlangen, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.
Read More

Today's Range

Now: $28.04
$27.02
$28.35

50 Day Range

MA: $25.99
$24.41
$27.32

52 Week Range

Now: $28.04
$16.19
$28.35

Volume

43,090 shs

Average Volume

39,860 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Siemens Healthineers?

The following equities research analysts have issued reports on Siemens Healthineers in the last year: AlphaValue, Bank of America Co., Barclays PLC, Berenberg Bank, Citigroup Inc., Commerzbank AG (CBK.F), Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., Morgan Stanley, Royal Bank of Canada, Stifel Nicolaus, and UBS Group AG.

What is the current price target for Siemens Healthineers?

0 Wall Street analysts have set twelve-month price targets for Siemens Healthineers in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Siemens Healthineers in the next year.

What is the current consensus analyst rating for Siemens Healthineers?

Siemens Healthineers currently has 2 sell ratings, 4 hold ratings and 7 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in SMMNY, but not buy more shares or sell existing shares.

What other companies compete with Siemens Healthineers?

How do I contact Siemens Healthineers' investor relations team?

The company's listed phone number is 49 9131 84 0. The official website for Siemens Healthineers is www.healthcare.siemens.de.